Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17068334rdf:typepubmed:Citationlld:pubmed
pubmed-article:17068334lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17068334lifeskim:mentionsumls-concept:C0081939lld:lifeskim
pubmed-article:17068334lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:17068334lifeskim:mentionsumls-concept:C1167250lld:lifeskim
pubmed-article:17068334lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:17068334lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:17068334lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:17068334pubmed:issue51lld:pubmed
pubmed-article:17068334pubmed:dateCreated2006-12-18lld:pubmed
pubmed-article:17068334pubmed:abstractTextGlycoprotein (GP) VI, the main signaling receptor for collagen on platelets, is expressed in complex with the FcR gamma-chain. The latter contains an immunoreceptor tyrosine-based activation motif, which becomes phosphorylated, initiating a signaling cascade leading to the rapid activation and aggregation of platelets. Previous studies have shown that signaling by immunoreceptor tyrosine-based activation motif-containing receptors is counteracted by signals from receptors with immunoreceptor tyrosine-based inhibitory motifs. Here we show, by immunoprecipitation, that the GPVI-FcR gamma-chain complex associates with the immunoreceptor tyrosine-based inhibitory motif-containing receptor, PECAM-1. In platelets stimulated with collagen-related peptide (CRP-XL), tyrosine phosphorylation of PECAM-1 precedes that of the FcR gamma-chain, implying direct regulation of the former. The GPVI-FcR gamma-chain complex and PECAM-1 were present in both lipid raft and soluble fractions in human platelets; this distribution was unaltered by activation with CRP-XL. Their association occurred in lipid rafts and was lost after lipid raft depletion using methyl-beta-cyclodextrin. We propose that lipid raft clustering facilitates the interaction of PECAM-1 with the GPVI-FcR gamma-chain complex, leading to the down-regulation of the latter.lld:pubmed
pubmed-article:17068334pubmed:languageenglld:pubmed
pubmed-article:17068334pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:citationSubsetIMlld:pubmed
pubmed-article:17068334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17068334pubmed:statusMEDLINElld:pubmed
pubmed-article:17068334pubmed:monthDeclld:pubmed
pubmed-article:17068334pubmed:issn0021-9258lld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:HeijnenHarry...lld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:AkkermanJan-W...lld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:FarndaleRicha...lld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:RelouIngrid...lld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:LeeFiona AFAlld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:17068334pubmed:authorpubmed-author:FoleyLoraineLlld:pubmed
pubmed-article:17068334pubmed:issnTypePrintlld:pubmed
pubmed-article:17068334pubmed:day22lld:pubmed
pubmed-article:17068334pubmed:volume281lld:pubmed
pubmed-article:17068334pubmed:ownerNLMlld:pubmed
pubmed-article:17068334pubmed:authorsCompleteYlld:pubmed
pubmed-article:17068334pubmed:pagination39330-8lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:meshHeadingpubmed-meshheading:17068334...lld:pubmed
pubmed-article:17068334pubmed:year2006lld:pubmed
pubmed-article:17068334pubmed:articleTitleLipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI-FcR gamma-chain complex in human platelets.lld:pubmed
pubmed-article:17068334pubmed:affiliationDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.lld:pubmed
pubmed-article:17068334pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17068334pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5175entrezgene:pubmedpubmed-article:17068334lld:entrezgene
entrez-gene:51206entrezgene:pubmedpubmed-article:17068334lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17068334lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17068334lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17068334lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17068334lld:pubmed